Disposition of 252 shares by Karen Foster of BioLife Solutions at 27.2 subject to Rule 16b-3
BLFS Stock | USD 25.74 0.93 3.49% |
Slightly above 54% of BioLife Solutions' investor base is interested to short. The analysis of overall sentiment of trading BioLife Solutions stock suggests that many investors are impartial at this time. BioLife Solutions' investing sentiment can be driven by a variety of factors including economic data, BioLife Solutions' earnings reports, geopolitical events, and overall market trends.
BioLife |
Filed transaction by BioLife Solutions Officer: Chief Quality And Operations. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Cash Flow Correlation
BioLife Solutions' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the BioLife Solutions' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
BioLife Solutions Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards BioLife Solutions can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
BioLife Solutions Maximum Pain Price Across April 17th 2025 Option Contracts
BioLife Solutions' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of BioLife Solutions close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of BioLife Solutions' options.
BioLife Solutions Fundamental Analysis
We analyze BioLife Solutions' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioLife Solutions using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioLife Solutions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
BioLife Solutions is currently under evaluation in target price category among its peers.
BioLife Solutions Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BioLife Solutions stock to make a market-neutral strategy. Peer analysis of BioLife Solutions could also be used in its relative valuation, which is a method of valuing BioLife Solutions by comparing valuation metrics with similar companies.
Peers
BioLife Solutions Related Equities
HAE | Haemonetics | 4.84 | ||||
WST | West Pharmaceutical | 3.08 | ||||
ATRC | AtriCure | 2.14 | ||||
ICUI | ICU Medical | 1.81 | ||||
ANGO | AngioDynamics | 0.00 | ||||
RMD | ResMed | 0.00 | ||||
TFX | Teleflex Incorporated | 0.00 | ||||
COO | Cooper Companies, | 0.00 | ||||
ATR | AptarGroup | 0.07 | ||||
ALC | Alcon AG | 0.29 | ||||
KRMD | Repro Med | 0.54 | ||||
AKYA | Akoya Biosciences | 8.29 |
Additional Tools for BioLife Stock Analysis
When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.